Raymed Labs Limted Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 4.27 Cr
as on 16-11-2024
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.87 Cr
as on 16-11-2024
- Revenue %
(FY 2023)
- Profit -108.32%
(FY 2023)
- Ebitda -142.07%
(FY 2023)
- Net Worth -8.01%
(FY 2023)
- Total Assets -36.84%
(FY 2023)
About Raymed Labs Limted
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 531207.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.27 Cr.
The company has closed loans amounting to ₹2.87 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Raymed Labs Limted India is Ajai Goyal as CFO. Ajai Goyal, Poonam Sharma, Harsh Prabhakar, and One other member serve as directors at the Company.
- CIN/LLPIN
L24111UP1992PLC014240
- Company No.
014240
- Stock Symbol
BSE : 531207
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1992
- Date of AGM
18 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Raymed Labs Limted?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ajai Goyal | CFO | 08-Aug-2022 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajai Goyal  | Whole-Time Director | 30-Mar-1992 | Current |
Poonam Sharma  | Director | 12-Aug-2021 | Current |
| Harsh Prabhakar | Director | 25-Aug-2015 | Current |
| Nisha Goyal | Director | 13-Jul-2002 | Current |
Financial Performance of Raymed Labs Limted.
Raymed Labs Limted, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 108.32% decrease in profit. The company's net worth dipped by a decrease of 8.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Raymed Labs Limted?
In 2023, Raymed Labs Limted had a promoter holding of 28.36% and a public holding of 71.64%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 09 Apr 2009 | ₹1.00 M | Satisfied |
Indian Overseas Bank Creation Date: 29 Mar 2003 | ₹5.50 M | Satisfied |
Indian Overseas Bank Creation Date: 29 Mar 2003 | ₹1.35 M | Satisfied |
How Many Employees Work at Raymed Labs Limted?
Unlock and access historical data on people associated with Raymed Labs Limted, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Raymed Labs Limted, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Raymed Labs Limted's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
